To further understand whether the brain barrier at the CP contributes to MS, and to search for novel biomarkers, we characterized here the CP transcriptome in the onset, remission and relapse phases of the murine experimental autoimmune encephalomyelitis (EAE) model of MS. Here, CP is linked to experimental autoimmune encephalomyelitis.